Advertisement

FDA Offers Speedier Approvals to Drug Companies Aligning With ‘National Priorities’

0

Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications

Marine Microplastic Levels Linked to Cardiometabolic Disease Prevalence

0

Prevalence of type 2 diabetes, coronary artery disease, stroke increased in coastal counties with very high versus low MMLs

Researchers Quantify Magnitude of Cardiovascular Risk Associated With Cannabis

0

Increased estimated risk ratios seen for nonfatal acute coronary syndrome, stroke, cardiovascular death

Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop...

0
By I. Edwards HealthDay Reporter WEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about...

‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warns

0
By Carole Tanzer Miller HealthDay Reporter TUESDAY, June 17, 2025 (HealthDay News) — The small, colorful bottles hawked at convenience stores, smoke shops and filling...

Virtual Reality Training Module May Aid Infection Control Efforts

0

Users report an overall positive experience for module covering cleaning and disinfecting portable medical equipment

Prenatal PFAS Exposure Linked to Elevated BP Through Adolescence

0

Each doubling of perfluoroheptanesulfonic acid linked to 9 and 17 percent higher risk for elevated BP at ages 6 to 12, 13 to 18 years, respectively, in male children

Survival Up for CABG With Surgical Ablation in Atrial Fibrillation

0

Medicare beneficiaries undergoing concomitant surgical ablation have risk-adjusted median survival advantage

Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials

0

In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9 percent with early and late discontinuation and nondiscontinuation, respectively

Adherence to Healthy Diet Improves Cardiometabolic Risk, Even Without Weight Loss

0

Authors say findings reframe clinical success of lifestyle interventions